Acne Patents (Class 514/859)
-
Patent number: 6284750Abstract: Disclosed are compounds of formula II: wherein A is as defined by the specification. Also disclosed are compositions containing the esters and methods for their use in the regulation of skin atrophy and in the treatment of skin disorders such as dry skin, dandruff, acne and eczema.Type: GrantFiled: January 26, 2000Date of Patent: September 4, 2001Assignee: Estee Lauder Inc.Inventors: Joseph Gubernick, Daniel H. Maes
-
Patent number: 6284233Abstract: The present invention relates to an antiwrinkle composition that includes, in a physiologically acceptable medium: a dispersion of a film-forming polymeric system containing at least one polymer capable of forming a film permeable to water vapor, having a Young's modulus ranging from 108 to 1010 N/m2 and producing, after application at a concentration of 7% in water and then drying, a retraction of the isolated stratum corneum greater than 1% at a temperature of 30° C. and a relative humidity of 40%, and a dendritic polyester polymer having terminal hydroxyl functional groups.Type: GrantFiled: September 17, 1999Date of Patent: September 4, 2001Assignee: L'OrealInventors: Pascal Simon, Veronique Chevalier
-
Patent number: 6280755Abstract: The invention concerns fatty acids uninterrupted by a methylene group as anti-inflammatory agents in superficial tissues of mammals, more particularly a pharmaceutical or cosmetic topical composition comprising, as an active ingredient, at least one fatty acid uninterrupted by a methylene group corresponding to formula (I), an salt or ester thereof, wherein R1 is a C1-C5 alkyl group and R2 is a C2-C6 alkyl group. Preferably, the fatty acid uninterrupted by a methylene group is 20:3(5,11,14). The fatty acid uninterrupted by a methylene group is also used for preparing a composition for modulating the metabolism of lipids in the superficial tissue of mammals.Type: GrantFiled: September 5, 2000Date of Patent: August 28, 2001Assignee: Societe L'Oreal S.A.Inventors: Alvin Berger, Andre Jomard
-
Patent number: 6277387Abstract: The invention relates to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist in a cosmetic, pharmaceutical or dermatological composition for treating sensitive skins. It relates especially to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist for preventing and/or combating skin irritations and/or sores and/or erythema and/or dysaesthetic sensations and/or sensations of inflammation and/or pruritus and/or prickling and/or tingling and/or discomfort and/or tightness of the skin and/or mucosae. It also relates to a composition containing a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist which limits or eliminates the irritant side-effects of certain products, and in particular of certain cosmetic, dermatological or pharmaceutical active agents.Type: GrantFiled: September 8, 1999Date of Patent: August 21, 2001Assignee: L'OrealInventors: Olivier De Lacharriere, Lionel Breton, Catherine Cohen
-
Patent number: 6277385Abstract: The present invention provides coolant compositions for topical application to the skin which can provide long-lasting cooling with low or reduced skin sting. The compositions comprise a mixture of specific type of acyclic carboxamide coolant with a specific type of 3-substituted-p-menthane coolant, an aqueous vehicle, and no more than about 30% C1-C6 monohydric alcohol.Type: GrantFiled: January 18, 1995Date of Patent: August 21, 2001Assignee: The Procter & Gamble CompanyInventor: William Michael Luke
-
Patent number: 6271268Abstract: A method of treating diseases caused by sebaceous gland disorders, in humans and animals, which comprises administering to said humans and animals a composition comprising a sebaceous gland secretion inhibiting amount of an active compound comprising an acyl coA cholesterol acyl transferase (ACAT) inhibitor or prodrug therefor. A composition for use in treating diseases caused by sebaceous gland disorders such as acne in humans and animals which comprises a sebaceous gland secretion inhibiting amount of an acyl coA cholesterol acyl tanferase (ACAT) inhibitor or prodrug therefor and, optionally, a pharmaceutically acceptable carrier.Type: GrantFiled: March 27, 2000Date of Patent: August 7, 2001Assignee: Pfizer IncInventor: James T. Mayne
-
Patent number: 6258385Abstract: The invention relates to the use of electron active molecular crystals comprising tetrasilver tetroxide (Ag4O4) for the treatment and cure of dermatological skin conditions (diseases) ranging from dermatitis, acne and psoiasis to herpes and skin ulcers.Type: GrantFiled: April 18, 2000Date of Patent: July 10, 2001Assignee: Marantech Holding, LLCInventor: Marvin S. Antelman
-
Patent number: 6258830Abstract: The present invention provides a stable gel formulation for topical treatment of skin conditions in humans. The stable gel formulation includes an active agent, having activity for treatment of acne and psoriasis, which is insoluble in water and a plurality of nonaqueous vehicles for both solubilizing said active agent and forming a gel therewith enabling topical application of the gel to a skin condition. The plurality of vehicles are each present in amounts, and in combination, to control release of the active agent from-the gel to the skin condition.Type: GrantFiled: March 1, 1999Date of Patent: July 10, 2001Assignee: Allergan Sales, Inc.Inventor: Prakash M. Charu
-
Patent number: 6254879Abstract: The invention concerns a new pharmaceutical agent for oral or topical administration in the treatment of protozoal diseases, in particular of leishmaniasis, which contains as the active substance one or several compounds having the general formula I in which R1 is a saturated or monounsaturated or polyunsaturated hydrocarbon residue with 12 to 20 C atoms and R2, R3 and R4 denote independently of one another hydrogen, a C1-C5 alkyl group, a C3-C6 cycloalkyl group or a C1-C5 hydroxyalkyl group whereby two of the residues R2, R3 and R4 can together form a C2-C5 alkylene group which, if desired, can be substituted with an —O—, —S— or NR5 group, in which R5 is hydrogen, a C1-C5 alkyl group, a C3-C6 cycloalkyl group or a C1-C5 hydroxyalkyl group as well as, if desired the usual pharmaceutical auxiliary, diluting, carrier or/and filling substances.Type: GrantFiled: July 23, 1999Date of Patent: July 3, 2001Assignees: Max-Planck-Gessellschaft zun Förderung der Wissenschaften e.V., Asta Medica AGInventors: Hansjörg Eibl, Clemens Unger, Jürgen Engel
-
Patent number: 6248340Abstract: The present invention generally relates to a composition useful for care of skin conditions and for skin protection and to a method for its preparation. The present invention further relates to a method for skin care and protection using said composition. More specifically, the present invention relates to a composition combining plant and algae extracts with water solutions from the Dead Sea especially useful for treating skin wrinkles and retaining skin moisture, to a method for the preparation thereof and to a method for skin care and protection comprising application of said composition.Type: GrantFiled: January 10, 2000Date of Patent: June 19, 2001Assignee: Dead Sea Laboratories, Ltd.Inventors: Zeev Maor, Shaul Yehuda
-
Patent number: 6248343Abstract: Antimicrobial alcohol-containing compositions and methods of using the compositions to disinfect surfaces and provide therapeutic benefits are disclosed.Type: GrantFiled: December 13, 1999Date of Patent: June 19, 2001Assignee: Ethicon, Inc.Inventors: Hanuman B. Jampani, Jerry L. Newman, Timothy Ellis
-
Patent number: 6228487Abstract: This invention involves skin cleaning products and tapes for removing keratotic plugs, dirt and other debris found on the skin and in skin pores and comprising a poly(vinyl acetamide) polymer based adhesive composition applied to a substrate backing material.Type: GrantFiled: December 31, 1998Date of Patent: May 8, 2001Assignee: National Starch and Chemical Investment Holding CorporationInventors: Doreen L. Howard, Gary T. Martino, Ian W. Cottrell
-
Patent number: 6225299Abstract: The pharmaceutical composition, especially for treating skin with seborrhea, Acne vulgaris and androgonically conditioned alopecia, contains a hormonal agent including the gestogen, dienogest, or a combination of dienogest and an estrogen, as active ingredient. Methods for treatment of this type of skin condition include topical application of the composition including the dienogest which results in an outstanding sebosuppression, a drastic reduction of androstandiol glucuronide and a moderate competitive blockage of androgen receptor sites. Galenic formulations are described which limit and/or prevent the permeation of the active ingredient through the skin.Type: GrantFiled: December 23, 1998Date of Patent: May 1, 2001Assignee: Jenapharm GmbH & Co. KGInventors: Siegfried Golbs, Michael Oettel, Michael Dittgen, Thomas Graser, Christoph Luderschmidt
-
Publication number: 20010000469Abstract: The present invention relates to a method for treatment of mammalian skin conditions where stimulated connective tissue synthesis is beneficial, comprising treating skin in need of such treatment with a safe and effective amount of 17-&agr;-estradiol.Type: ApplicationFiled: December 19, 2000Publication date: April 26, 2001Inventors: Gerard J. Gendimenico, James A. Mezick
-
Patent number: 6221403Abstract: A topical composition for impregnating a bandage comprises zinc oxide in a stable oil in water emulsion. The emulsion comprises one or more fats or oils, one or more emulsifying agents, at least one water soluble gum and water. No preservative is required.Type: GrantFiled: February 8, 1995Date of Patent: April 24, 2001Assignee: Seton Healthcare Group PLCInventor: Michael Robert Nesbit
-
Patent number: 6221911Abstract: This invention relates to the use of topically applied thyroid hormone compounds and thyroid hormone-like compounds which are receptor binding ligands, either agonists or antagonists, to improve the appearance of the skin and underlying subcutaneous fat and improve certain medical conditions when applied topically. These compounds can be used to treat skin conditions such as stria, cellulite, roughened skin, actinic skin damage, intrinsically aged skin, photodamaged kin, lichen planus, ichthyosis, acne, psoriasis, wrinkled skin, corticosteroid atrophy, collagen deficient skin, and to diminish the size and improve the appearance of skin scarring from surgical or naturally occurring wounds, and to reduce the incidence of hyperkeratotic scarring. The thyroid agonists and antagonists may also promote differentiation and amelioration of dedifferentiated skin in premalignant lesions.Type: GrantFiled: March 9, 1998Date of Patent: April 24, 2001Assignee: Karo Bio ABInventors: Thomas N. Lavin, Anders B. Vahlquist
-
Patent number: 6217887Abstract: The present invention relates to a leave-on antimicrobial composition comprising from about 0.001% to about 5% of an antimicrobial active; from about 0.5% to about 10% of an anionic surfactant; from about 0.1% to about 10% of a proton donating agent, wherein the proton donating agent is such that the composition is essentially free of C4-C20 alkyl fatty acid; and from about 0% to about 98.85% of water; wherein the composition is adjusted to a pH of from about 3.0 to about 6.0; wherein the leave-on antimicrobial composition has a One-wash Immediate Germ Reduction Index of greater than about 50%; and wherein the leave-on antimicrobial composition has a Mildness Index of greater than 0.3. The invention also encompasses methods for moisturizing skin, reducing germs on the skin, and providing residual effectiveness versus Gram positive bacteria using these products.Type: GrantFiled: June 1, 1999Date of Patent: April 17, 2001Assignee: The Procter & Gamble CompanyInventors: Peter William Beerse, Jeffrey Michael Morgan, Kathleen Grieshop Baier, Theresa Anne Bakken Schuette, Raymond Wei Chen
-
Patent number: 6190691Abstract: The present invention provides a number of screening methods for evaluating compounds capable of suppressing cytokine production either in vitro or in vivo. The methods generally involve stimulating the production of a cytokine in a cell, exposing a portion of the cells to a putative cytokine modulating agent and determining subsequent levels of cytokine production in the cells. Additionally, the present invention provides certain compounds identified by this method.Type: GrantFiled: June 15, 1998Date of Patent: February 20, 2001Assignee: Adolor CorporationInventor: Vivien H. W. Mak
-
Patent number: 6183747Abstract: Novel herbal extracts provide potent efficacy in the treatment of acne and furuncle. The formulated extracts of Momordica charantia L. are from either the whole plant or parts of the plant. The extracts have been formulated into aqueous solution, pads, and/or lotion. These formulations have been provided to treat acne and furuncle 2 to 3 times a day. It has demonstrated the ability to manage various grades of acne, from mild, moderate to severe, which include comedos, papules, pustules and nodules. Significant improvement is visible within five days. There are no observed either long-term or short-term side reactions.Type: GrantFiled: July 14, 1999Date of Patent: February 6, 2001Inventor: Kaijun Ren
-
Patent number: 6180669Abstract: A compound effect for the treatment of dermatological disorders comprises a mono- or diester of an &agr;,&ohgr;-dicarboxylic acid, wherein the alcohol moiety of the said ester comprises a keratolytically active alcohol. The compound may have the formula, where n is in the range of 6 to 12; m is in the range of 0 to 8; R′ is selected from the group consisting of H, alkyl, aryl, alkenyl, benzyl, OH, NHR″, CONHR″ and COOR″; R″ is selected from the group consisting of alkyl, aryl, alkenyl, and benzyl; and Y is selected from the group consisting of H, alkyl, aryl, alkenyl, benzyl and X.Type: GrantFiled: April 5, 1999Date of Patent: January 30, 2001Assignee: Tamarkin Pharmaceutical Innovation Ltd.Inventor: Dov Tamarkin
-
Patent number: 6180662Abstract: The invention relates to the use of a) a compound or several compounds from the group consisting of flavonoids, or b) an active compound combination comprising a compound or several compounds chosen from the group consisting of flavonoids, in combination with a compound or several compounds chosen from the group consisting of cinnamic acid derivatives, and if appropriate additionally in each case a compound or several compounds from one of the groups or several of the groups c) of the antioxidants or d) of the endogenous energy metabolism metabolites or e) of the endogenous enzymatic antioxidant systems and synthetic derivatives thereof (mimics) or f) of the antimicrobial action systems or g) of the antiviral action systems or h) active compounds of the known, conventional treatment forms in each case for the treatment or prophylactic treatment of hyperreactive skin predisposed to dermatitis or deficient, hypoactive skin or dermatoses.Type: GrantFiled: May 6, 1999Date of Patent: January 30, 2001Assignee: Beiersdorf AGInventors: Ghita Lanzendörfer, Franz St{umlaut over (a)}b, Sven Untiedt
-
Patent number: 6174533Abstract: Disclosed are topical compositions which provide good coverage of skin imperfections, e.g., pores and uneven skin tone, while retaining a natural skin appearance. The compositions contain a particulate material having a refractive index of at least about 2, e.g., TiO2.Type: GrantFiled: April 17, 1998Date of Patent: January 16, 2001Assignee: The Procter & Gamble CompanyInventors: James Pedrosa SaNogueira, Jr., Nancy Coultrip Dawes, Mark Richard Sine
-
Patent number: 6174892Abstract: The instant invention involves a method of treating and/or reversing androgenic alopecia and promoting hair growth, and methods of treating acne vulgaris, seborrhea, and female hirsutism, by administering to a patient in need of such treatment a 5&agr;-reductase 2 inhibitor, such as finasteride, in a dosage amount under 5 mgs/day.Type: GrantFiled: November 24, 1999Date of Patent: January 16, 2001Assignee: Merck & Co., Inc.Inventors: Glenn J. Gormley, Keith D. Kaufman, Elizabeth Stoner, Joanne Waldstreicher
-
Patent number: 6171593Abstract: A method of treating skin disorders using a extract from the plant Mullein (genus Verbascum) and a composition including an extract from the plant Mullein (genus Verbascum) are described. The extract is obtained by cooking the leaves and roots of the plant Mullein in a pressure cooker with water. The resulting liquid extract is canned according to standard home canning procedures. The method is accomplished by applying the liquid extract to affected areas of the skin twice daily. Most subjects experience positive results within a period of approximately two weeks. Skin disorders that have been treated using this extract include the sun exposure related skin disorders, actinic keratoses, lentigines, seborrheic keratoses, and the inflammatory skin disorders including prurigo, psoriasis, and contact dermatitis. The skin cancer, malignant melanoma, has also been treated using this method.Type: GrantFiled: May 13, 1997Date of Patent: January 9, 2001Inventor: Johnny L. Williams
-
Patent number: 6168798Abstract: The invention provides methods and compositions which are mild and nonirritating for reducing and eliminating skin disorders, particularly blemishes and redness associated with acne. The hydroalcoholic compositions of the invention contain a keratolytic compound, preferably a &bgr;-hydroxy carboxylic acid, more preferably salicylic acid or pharmaceutically acceptable salt thereof; and a glycerophosphate ester or salt, formulated with pharmaceutically acceptable carriers. Preferred glycerophosphate salts for use in the methods and compositions of the invention are sodium glycerophosphate and calcium glycerophosphate. Additional anti-irritancy agents are not required in the compositions of the present invention, as the glycerophosphate salt component uniquely endows the compositions with nonirritant properties. Other components which may be formulated into the compositions of the invention include fragrances, colorants, emollients, humectants and antimicrobial agents.Type: GrantFiled: February 3, 1997Date of Patent: January 2, 2001Assignee: Bristol-Myers Squibb CompanyInventors: David P. O'Halloran, Deborah Rudtke, Joyce Mayes-Smith
-
Patent number: 6159479Abstract: A composition containing a salicylic acid derivative, a solubilizer, a coupler, and water.Type: GrantFiled: September 16, 1997Date of Patent: December 12, 2000Assignee: L'orealInventor: Carlos O. Pinzon
-
Patent number: 6159493Abstract: A formulation and a method for manufacturing an acne extraction patch. Water is added into polyvinyl alcohol and polyvinyl pyrrolidone to form an polymer solution. An adequate excipient is further added to form an optimal formulation. The formulation is coated directly onto the hydrophilic nonwovens or the nonwovens are placed over the release liner after coating the release liner with silicon coating. After the steps described above, the nonwovens are put into the dry oven for a two-step drying method at 55-90.degree. C., and 80-95.degree. C. A die-cut and package machine is used to cut an adequate patch. The patch is moistened with water and applied to the face or nose. The water solution of the formulation penetrates into the hair follicles or sebaceous glands. The lug of acne sticks to the polymer patch as the water evaporates. The acne is extracted from the hair follicle as the patch is removed.Type: GrantFiled: February 11, 1998Date of Patent: December 12, 2000Assignee: Caleb Pharmaceuticals, Inc.Inventors: Shu-Juan Chen, Chao-Wei Liao, Chien-Hsin D. Cheng
-
Patent number: 6150422Abstract: A stable gelled composition, containing at least one lipophilic active agent sensitive to oxygen or to water or to both, and a solvent which contains, as gelling agent, at least one polysaccharide alkyl ether formed of units containing at least two different glycoside rings, each unit containing at least one hydroxyl group substituted with a saturated hydrocarbon alkyl group.Type: GrantFiled: March 11, 1997Date of Patent: November 21, 2000Assignee: L'OrealInventors: Didier Gagnebien, Pascal Simon
-
Patent number: 6139850Abstract: Composition and methods are provided for inhibiting skin irritation attributable to chemical irritants or environmental conditions, by the application of an anti-irritant amount of aqueous-soluble strontium cation.Type: GrantFiled: June 23, 1997Date of Patent: October 31, 2000Assignee: Cosmederm TechnologiesInventors: Gary S. Hahn, David O. Thueson
-
Patent number: 6136806Abstract: A rosacea treating agent is provided, which is effective even on intractable rosacea which cannot be cured completely by antibiotics such as minocycline, has low toxicity, causes little side effect, and is of long duration. The rosacea treating agent of the present invention comprises, as an active ingredient, at least one selected from the group consisting of benzoheterocyclic derivatives represented by the following formula (1): ##STR1## wherein R is a lower alkyl group; and X is a halogen atom, and salts thereof.Type: GrantFiled: November 20, 1998Date of Patent: October 24, 2000Assignee: Otsuka Pharmaceutical Co., Ltd.Inventor: Norbert Hittel
-
Patent number: 6136296Abstract: The present invention relates to personal care compositions. These compositions comprise an adhesive copolymer and a solvent for the copolymer selected from the group consisting of water, ethanol, n-propanol, isopropanol, acetone, propylene glycol, and mixtures thereof. The compositions, when dried, exhibit a cohesive strength of greater than about 0.5 kgf/mm.sup.2, a total energy absorption per unit volume of greater than about 0.55 kgfmm/mm.sup.3, and an impact strength of greater than about 7000 ergs. Preferred are hairspray embodiments of the present invention having improved removeability from hair as defined by a hair stiffness value of from 0 to about 3.5 (0 to 4 scale) and a hair flaking value of from 0 to about 3.5 (0 to 4 scale), which values are determined by the removeability methodology defined herein.Type: GrantFiled: September 29, 1997Date of Patent: October 24, 2000Assignee: The Procter & Gamble CompanyInventors: Sanjeev Midha, Raymond Edward Bolich, Jr., Kathleen Bridget Jividen
-
Patent number: 6133326Abstract: A method of treating diseases caused by sebaceous gland disorders, in humans and animals, which comprises administering to said humans and animals a composition comprising a sebaceous gland secretion inhibiting amount of an active compound comprising an acyl coA cholesterol acyl transferase (ACAT) inhibitor or prodrug therefor.A composition for use in treating diseases caused by sebaceous gland disorders such as acne in humans and animals which comprises a sebaceous gland secretion inhibiting amount of an acyl coA cholesterol acyl tanferase (ACAT) inhibitor or prodrug therefor and, optionally, a pharmaceutically acceptable carrier.Type: GrantFiled: August 31, 1994Date of Patent: October 17, 2000Assignee: Pfizer IncInventor: James T. Mayne
-
Patent number: 6126947Abstract: An inhibitor of cholesterol synthesis is used for the treatment, alleviation or prevention of skin disorders.Type: GrantFiled: October 15, 1997Date of Patent: October 3, 2000Assignee: Ramot Univ. Authority for App. Research & Indus. Dev. Ltd.Inventors: Naphtali Savion, Sara Brenner
-
Patent number: 6117843Abstract: A pharmaceutical composition containing clindamycin and benzoyl peroxide is disclosed for the treatment of acne. The composition is stable for several months when stored at room temperature. Methods of preparing and of using the composition are disclosed.Type: GrantFiled: May 13, 1997Date of Patent: September 12, 2000Assignees: Lloyd J. Baroody, Gordon J. DowInventors: Lloyd J. Baroody, Gordon J. Dow, Debra A. Dow, Robert Lathrop
-
Patent number: 6113928Abstract: A stable non-alcoholic cosmetic composition containing 13-trans retinal which is an oil-in-water emulsion in which the fatty phase constituents have a peroxide number no greater than about 5, and in which the fatty phase includes 10-15% by weight of capric/caprylic triglycerides and 0.02-0.5% by weight of the antioxidant BHT, and method of making the same.Type: GrantFiled: July 31, 1998Date of Patent: September 5, 2000Assignee: Pierre Fabre Dermo-CosmetiqueInventors: Laurent Nogueira, Nicole Peyrot
-
Patent number: 6106848Abstract: Stable, topically applicable oil-in-water bioaffecting emulsions having intermediate viscosity, characteristically ranging from 3 to 10 Pa.multidot.s, comprise (a) from 30% to 50% by weight of at least one pro-penetrating glycol, (b) at least one emulsifying agent, advantageously an anionic amphiphilic polymer, and (c) at least one biologically active agent, for example an active agent that modulates skin differentiation and/or proliferation and/or pigmentation, an anti-inflammatory, an antibacterial, an antifungal, etc.Type: GrantFiled: September 22, 1997Date of Patent: August 22, 2000Assignee: Centre International de Recherches DermatologiquesInventors: Isabelle Preuilh, Nathalie Willcox
-
Patent number: 6106851Abstract: The present invention relates to a rinse-off antimicrobial cleansing composition comprising from about 0.1% to about 5.0%, by weight of the cleansing composition, of an antimicrobial active; from about 6% to about 16%, by weight of the cleansing composition, of an anionic surfactant, wherein at least about 67% of the anionic surfactant is selected from the group consisting of Class A surfactants, Class C surfactants, and mixtures thereof, wherein the ratio of Class A surfactant to Class C is from about 100:0 to about 1.5:1; from about 2% to about 4%, by weight of the cleansing composition, of a proton donating agent having a Biological Activity Index, Z, of greater than about 0.75, wherein the proton donating agent is such that the composition is essentially free of C.sub.4 -C.sub.20 alkyl fatty acid, and wherein from about 0.Type: GrantFiled: June 1, 1999Date of Patent: August 22, 2000Assignee: The Procter & Gamble CompanyInventors: Peter William Beerse, Jeffrey Michael Morgan, Kathleen Grieshop Baier, Robert Gregory Bartolo, Theresa Anne Bakken Schuette
-
Patent number: 6106818Abstract: A method for removing dead surface cells, dirt, oil, or blackheads from the skin, and preventing or ameliorating the effects of blemishes or acne vulgaris, comprising applying to the skin a laminate comprised of a fabric strip and a solvent activated composition containing at least one nonionic polymer in combination with at least one skin conditioning agent, leaving the laminate on the skin until the solvent has substantially evaporated, and peeling the laminate off the skin, thereby removing dead surface cells, dirt, oil, or blackheads from the skin; as well as related articles and compositions.Type: GrantFiled: August 31, 1998Date of Patent: August 22, 2000Assignee: Revlon Consumer Products CorporationInventors: Reilly Canay Dulog, James Joseph Ferone, Beverly Ann Reisinger, Patricia Beatrice Siuta
-
Patent number: 6093411Abstract: The present invention relates to compositions for preventing or treating skin disorders using flavonoid compounds. The present invention also relates to methods for regulating skin condition.Type: GrantFiled: March 12, 1999Date of Patent: July 25, 2000Assignee: The Procter & Gamble CompanyInventor: Donald Lynn Bissett
-
Patent number: 6093408Abstract: The present invention provides compositions and methods for treatment of human skin. Such methods include those for regulating sebum on facial skin of a human subject, comprising applying to said subject an emulsion composition comprising(a) an anhydrous silicone mixture comprising(i) an ethylene oxide/propylene oxide silicone copolymer;(ii) an ethylene oxide silicone copolymer;(iii) a silicone gum; and(iv) a silicone fluid; and(b) water.Type: GrantFiled: October 25, 1996Date of Patent: July 25, 2000Assignee: The Procter & Gamble CompanyInventors: Erik John Hasenoehrl, Jeanne Marie Ponte, Anthony Daniel Sabatelli
-
Patent number: 6060085Abstract: The present invention generally relates to pharmaceutical compositions that enable control of drug delivery properties and the development of optimal drug delivery strategies customized for particular drugs and particular diseases. The composition includes a dissolved pharmaceutical that has the capacity to permeate the stratum corneum layer of the epidermis and become available systemically, and a pharmaceutical in a microparticulate state that does not readily cross the stratum corneum of the epidermis. The dissolved and microparticulate pharmaceuticals may be the same or different pharmaceuticals. Methods for the preparation and use of the compositions are also provided. In a preferred embodiment, the invention finds particular use in a formulation for the topical application of dapsone for the treatment of acne. In another preferred embodiment, the invention finds particular use for the treatment of herpes lesions.Type: GrantFiled: November 30, 1998Date of Patent: May 9, 2000Inventor: David W. Osborne
-
Patent number: 6048533Abstract: The present invention relates to the administration of an effective amount of turmeric for the treatment of various health ailments and also as a food supplement to promote health and vitality. The turmeric is especially useful for the treatment of skin disorders, such as acne, when administered orally. It can also be applied topically as a whitened or bleached composition. It can also be used to treat liver and stomach disorders, skin discoloration, constipation, and hemorrhoids.Type: GrantFiled: September 1, 1998Date of Patent: April 11, 2000Inventor: Van Bich Nguyen
-
Patent number: 6028118Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, anti-tumoral, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a homogenate of cartilage in an aqueous solution, this homogenate being separated in a solid fraction (SOLID EXTRACT) and a liquid fraction which was further fractionated to obtain a LIQUID EXTRACT having molecules of a molecular weight comprised between 0 to 500 kDa. The composition of the liquid extract has then been investigated by different ways. Further fractionation of this extract led to the preliminary characterization of some of its active components.Type: GrantFiled: August 8, 1996Date of Patent: February 22, 2000Assignee: Les Laboratoires Aeterna Inc.Inventors: Eric Dupont, Paul Brazeau, Christina Juneau, Daniel H. Maes, Kenneth Marenus
-
Patent number: 6025334Abstract: The present invention relates to cartilage extracts and to a method of producing the same. Shark cartilage extracts having anti-angiogenic, direct anti-tumor proliferating, anti-inflammatory and anti-collagenolytic activities have been obtained by an improved process. The process comprises the steps of obtaining a homogenate of cartilage in an aqueous solution, this homogenate being centrifuged and further fractionated to obtain a total extract having molecules of a molecular weight comprised between 0 to 500 KDa. The composition of the liquid extract has then been investigated by different ways. Further fractionation of this extract led to the preliminary characterization of some of its active components. Due to the multiplicity of biological activities of the total liquid extract, it can be used for treating numerous diseases or conditions such as those having components selected from the group consisting of tumor proliferation, angiogenesis, inflammation and collagenolysis.Type: GrantFiled: October 30, 1995Date of Patent: February 15, 2000Assignee: Les Laboratoires Aeterna Inc.Inventors: Eric Dupont, Paul Brazeau, Christina Juneau, Daniel H. Maes, Kenneth Marenus
-
Patent number: 6017938Abstract: The present invention relates to a method of treating acne using short-term contact with an acetylenic retinoid, preferably tazarotene and related compounds.Type: GrantFiled: July 28, 1998Date of Patent: January 25, 2000Inventor: Susan Bershad
-
Patent number: 6013637Abstract: Compositions and methods for the treatment of acne including a peroxide and an antibiotic from the lincomycin family of antibiotics are disclosed.Type: GrantFiled: June 12, 1998Date of Patent: January 11, 2000Assignee: Dermik Laboratories Inc.Inventors: Robert W. Klein, Albert M. Packman
-
Patent number: 6004566Abstract: The present invention relates to a delivery system which includes a bioactive drug or cosmetic substance presented in the form of submicron oil spheres alone, or drugs or cosmetic substances in a combination with the oil spheres in an aqueous suspension or emulsion. Optionally, a skin penetration enhancer may be included in such formulations. Such preparations achieve improved bioavailability and exert larger pharmacological effects than an equivalent dose of the drug or cosmetic formulated in conventional creams, lotions or oleaginous bases.Type: GrantFiled: March 23, 1993Date of Patent: December 21, 1999Assignee: Pharmos Corp.Inventors: Doron Friedman, Joseph Schwartz, Haim Aviv
-
Patent number: 5997892Abstract: According to one embodiment of the topical therapeutic composition of the present invention, the composition comprises a combination of sulfur and Vitamin E in a range of about three parts of Vitamin E to one part sulfur to about equal parts of sulfur and Vitamin E. Preferably, the sulfur is in powder form, for example, sublimed sulfur, prior to mixing with the Vitamin E. The Vitamin E comprises either natural vitamin E (d-alpha tocopherol) or synthetic vitamin E (dl-alpha tocopherol) or a blend of both natural vitamin E (d-alpha tocopherol) and synthetic vitamin E (dl-alpha tocopherol).Type: GrantFiled: September 23, 1998Date of Patent: December 7, 1999Inventor: Gary Don Camp
-
Patent number: 5993787Abstract: Entirely anhydrous topical preparations comprising (I) propylene carbonate, (II) one or more short carbon-chain alcohols and/or glycols including ethanol, isopropyl alcohol, propylene glycol, butylene glycol, polyethylene glycol, hexylene glycol, methoxypolyethylene glycol, and (III) either or both of glycerol and one or more therapeutically or cosmetically active ingredients.Type: GrantFiled: September 13, 1996Date of Patent: November 30, 1999Assignee: Johnson & Johnson Consumer Products, Inc.Inventors: Ying Sun, Jue-Chen Liu, Elisabeth S. Kimbleton, Jonas C. T. Wang
-
Patent number: 5993833Abstract: The invention relates to the use of a histamine antagonist, an interleukin-1-antagonist and/or a TNF antagonist in a cosmetic, pharmaceutical or dermatological composition for treating sensitive skins. It relates especially to the use of a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist for preventing and/or combating skin irritations and/or sores and/or erythema and/or dysaesthetic sensations and/or sensations of inflammation and/or pruritus and/or prickling and/or tingling and/or discomfort and/or tightness of the skin and/or mucosae. It also relates to a composition containing a histamine antagonist, an interleukin-1 antagonist and/or a TNF alpha antagonist which limits or eliminates the irritant side-effects of certain products, and in particular of certain cosmetic, dermatological or pharmaceutical active agents.Type: GrantFiled: June 20, 1997Date of Patent: November 30, 1999Assignee: Societe L'Oreal S.A.Inventors: Olivier De Lacharriere, Lionel Breton, Catherine Cohen